Effects of risedronate and alfacalcidol on parameters of atherosclerosis in type 2 diabetes patients with osteoporosis.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2009
At a glance
- Drugs Alfacalcidol (Primary) ; Risedronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 29 Jun 2009 New trial record
- 22 Jun 2009 Results reported in UMIN registry record.